Coagulation factor ⅷ quality control substance preparation method
A technology for coagulation factors and quality control substances, which is applied in the preparation of test samples, material inspection products, biological tests, etc., can solve the problems of single level, high product price, affecting the accuracy of coagulation factor VIII determination results, etc. The ability to reduce the cost of detection, the effect of good stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0014] In conjunction with embodiment, further set forth the present invention:
[0015] The embodiment takes the preparation of a blood coagulation factor VIII quality control product with an activity of 30% as an example.
[0016] (1) Add and mix the blood collected from human veins and anticoagulant at a volume ratio of 9:1, centrifuge at 2°C to 8°C for 15 minutes at a speed of 2500rpm, separate and absorb the upper layer of plasma, and mix multiple portions of plasma, That is, multiple servings of mixed plasma; the anticoagulant is trisodium citrate solution with a concentration of 0.109mol / L;
[0017] (2) Add 2 to 10 grams of disodium ethylenediamine tetraacetate for every 1000 milliliters of mixed plasma; incubate at 37°C for 1 to 2 hours;
[0018] (3) After the above treatment, the plasma was dialyzed in dialysate at 2-8°C for 24 hours. The dialysate was sodium chloride 5-10 g / L, imidazole 2-5 g / L, pH 7.2; the volume ratio of dialysate to plasma was 50 ~100:1, change ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 